Hyundai Bioscience

048410.KQ

6.49 USD

-0.08

-1.22%

Overview

Last close

6.49 usd

Market cap

311.80M usd

52 week high

17.93 usd

52 week low

6.33 usd

Target price

N/A usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

39.5489

Price/Book Value

3.6035

Enterprise Value

269.49M usd

EV/Revenue

34.3331

EV/EBITDA

-64.6317

Key financials

Revenue TTM

7.85M usd

Gross Profit TTM

6.74M usd

EBITDA TTM

-2.89M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

96.62M usd

Net debt

N/A usd

About

Hyundai Bioscience Co., Ltd. operates as a biotechnology company. The company provides Vitabrid C12, a vitamin C product that delivers active vitamin C into the skin. It develops Polytaxel, a drug for pancreatic cancer and solid tumors; and CP-COV03 drug for Covid 19. The company was founded in 2000 and is based in Seoul, South Korea.